8.27 USD
-0.08 (-0.96%)
8.27 USD
0 (0%)
Taking everything into account, JYNT scores 3 out of 10 in our fundamental rating. JYNT was compared to 101 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. JYNT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
JYNT had negative earnings in the past year.
In the past year JYNT had a positive cash flow from operations.
In multiple years JYNT reported negative net income over the last 5 years.
JYNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -1.40%, JYNT perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.27%, JYNT is in line with its industry, outperforming 47.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
JYNT has a better Gross Margin (78.26%) than 93.07% of its industry peers.
In the last couple of years the Gross Margin of JYNT has declined.
The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JYNT has more shares outstanding
Compared to 5 years ago, JYNT has more shares outstanding
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.71 indicates that JYNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.71, JYNT is in line with its industry, outperforming 59.41% of the companies in the same industry.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.71 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
JYNT has a Current Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
JYNT has a Current ratio of 1.83. This is in the better half of the industry: JYNT outperforms 72.28% of its industry peers.
A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
The Quick ratio of JYNT (1.83) is better than 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 99.03% over the past year.
JYNT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.15%.
The Revenue has been growing slightly by 1.36% on average over the past years.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.72% yearly.
The Revenue is expected to decrease by -20.57% on average over the next years. This is quite bad
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 22.52 indicates a rather expensive valuation of JYNT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (36.22), we can say JYNT is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.52 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as JYNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.33 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 72.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.55%
EPS Next 3Y72.72%
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.27
-0.08 (-0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners77.63%
Inst Owner Change-1.63%
Ins Owners8.65%
Ins Owner Change2.1%
Market Cap122.97M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts78.18
Price Target10.97 (32.65%)
Short Float %5.03%
Short Ratio5.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-27.73%
PT rev (3m)-27.73%
EPS NQ rev (1m)-54.29%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)-5.58%
Revenue NQ rev (3m)-5.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.52 | ||
| P/S | 1.34 | ||
| P/FCF | 75.33 | ||
| P/OCF | 40.04 | ||
| P/B | 5.42 | ||
| P/tB | 5.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.37
Fwd EY4.44%
FCF(TTM)0.11
FCFY1.33%
OCF(TTM)0.21
OCFY2.5%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.71 |
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.77%
EBIT Next 3Y73.96%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 98.84% in the next year.